The Newcastle upon Tyne Hospitals NHS Foundation Trust

61 capabilities Verified Oct 2026 One of 2,018 in United Kingdom
Send Enquiry

Send one structured enquiry and we chase the reply for you. No cold email, no chasing.

Details

Northern Genetics Service, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Institute of Genetic Medicine, Central Parkway, Newcastle upon Tyne
Newcastle upon Tyne NE1 3BZ , United Kingdom

Accreditation

Active UKAS 9028
+44 (0)191 282 0848
nhs.net Prefer to enquire through us? Send an enquiry
Unclaimed listing · Claim this lab

Accreditation Details

Accreditation Body

UKAS

Number

9028

Status

Active

Accreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official UKAS records.

Download Scope PDF

Other locations

The Newcastle upon Tyne Hospitals NHS Foundation Trust Times Square The Newcastle upon Tyne Hospitals NHS Foundation Trust High Heaton The Newcastle upon Tyne Hospitals NHS Foundation Trust Framlington Place

Test Capabilities (61)
Standard Reference Description Category
MEASUREMENT Measurement Electrical
G-Banding/Karyotyping G-banding/Karyotyping: | Culturing and processing of human Histopathology / Cytology
Immunohistochemistry analysis and interpretation of data to progress a diagnosis Antibodies listed below:  -Dystroglycan  -Sarcoglycan  -Spectrin Caveolin 3 Collagen VI Desmin Fast myosin  -Sarcoglycan Laminin  2 chain Laminin  5 chain MHC Class 1 Myosin heavy chain (neonatal) Myotilin nNOS p62 Slow myosin STIM1 Utrophin Valosin-containing protein measurement Immunohistochemistry analysis and interpretation of data to progress a diagnosis Antibodies listed below:  -Dystroglycan  -Sarcoglycan  -Spectrin Caveolin 3 Collagen VI Desmin Fast myosin  -Sarcoglycan Laminin  2 chain Laminin  5 chain MHC Class 1 Myosin heavy chain (neonatal) Myotilin nNOS p62 Slow myosin STIM1 Utrophin Valosin-containing protein measurement Histopathology / Cytology
Tumours Tumours Histopathology / Cytology
ALK-activating variants in neuroblastoma, HFE variants c.845G>A p.(Cys282Tyr) & c.187C>G p.(His63Asp) FLT3-TKD MYD88 ALK-activating variants in neuroblastoma, HFE variants c.845G>A p.(Cys282Tyr) & c.187C>G p.(His63Asp) FLT3-TKD MYD88 Molecular Diagnostics / PCR
Angelman/Prader Willi syndrome by bisulphite conversion Angelman/Prader Willi syndrome by bisulphite conversion Molecular Diagnostics / PCR
BCR-ABL monitoring in chronic myeloid leukaemia measurement BCR-ABL monitoring in chronic myeloid leukaemia measurement Molecular Diagnostics / PCR
BRAF BRAF Molecular Diagnostics / PCR
Classification of Microsatellite Classification of Microsatellite Molecular Diagnostics / PCR
Confirmatory and cascade testing Confirmatory and cascade testing Molecular Diagnostics / PCR
Confirmatory testing of fusion events by RT-PCR-analytic capacity as per GENE36 measurement Confirmatory testing of fusion events by RT-PCR-analytic capacity as per GENE36 measurement Molecular Diagnostics / PCR
Cystic Fibrosis (including neonatal screening) Cystic Fibrosis (including neonatal screening) Molecular Diagnostics / PCR
DPYD Mutation Detection for the following targets: DPYD c.1905+1G>A DPYD*2A rs3918290 DPYD c.2846A>T p.(Asp949Val) rs67376798 DPYD c.1679T>G p.(Ile560Ser) DYPD*13 rs55886062 DPYD c.1236G>A p.(Glu412Glu) HapB3 rs56038477 DPYD c.1129-5923C>G HapB3 rs75017182 measurement DPYD Mutation Detection for the following targets: DPYD c.1905+1G>A DPYD*2A rs3918290 DPYD c.2846A>T p.(Asp949Val) rs67376798 DPYD c.1679T>G p.(Ile560Ser) DYPD*13 rs55886062 DPYD c.1236G>A p.(Glu412Glu) HapB3 rs56038477 DPYD c.1129-5923C>G HapB3 rs75017182 measurement Molecular Diagnostics / PCR
Detection of SNVs and small indels and fusions associated with myeloid neoplasms -analytic capacity as per GENE119 Detection of SNVs and small indels and fusions associated with myeloid neoplasms -analytic capacity as per GENE119 Molecular Diagnostics / PCR
Detection of SNVs, small indels and CNVs associated with Familial Detection of SNVs, small indels and CNVs associated with Familial Molecular Diagnostics / PCR
Detection of insertions, deletions, substitutions, and other polymorphisms in NRAS Detection of insertions, deletions, substitutions, and other polymorphisms in NRAS Molecular Diagnostics / PCR
Detection of known or unknown sequence changes - analytic capacity as per SOPS measurement Detection of known or unknown sequence changes - analytic capacity as per SOPS measurement Molecular Diagnostics / PCR
Detection of nucleic acid sequence variants – SNVs, small indels and breakpoints Detection of nucleic acid sequence variants – SNVs, small indels and breakpoints Molecular Diagnostics / PCR
Determination of copy number changes Determination of copy number changes Molecular Diagnostics / PCR
EGFR EGFR Molecular Diagnostics / PCR
FLT3/NPM1 in AML FLT3/NPM1 in AML Molecular Diagnostics / PCR
FLUIDS | GENE35 FLUIDS | GENE35 Molecular Diagnostics / PCR
Genomics analysis for the purpose of clinical diagnosis of rare disease, inherited and acquired cancer Genomics analysis for the purpose of clinical diagnosis of rare disease, inherited and acquired cancer Molecular Diagnostics / PCR
Genomics analysis for the purpose of clinical diagnosis of rare disease, inherited and acquired cancer measurement Genomics analysis for the purpose of clinical diagnosis of rare disease, inherited and acquired cancer measurement Molecular Diagnostics / PCR
Genomics analysis for the purpose of clinical diagnosis or rare disease and cancer Genomics analysis for the purpose of clinical diagnosis or rare disease and cancer Molecular Diagnostics / PCR
Instability (MSI) status (stable/unstable) and genotyping of BRAF & NRAS/KRAS Instability (MSI) status (stable/unstable) and genotyping of BRAF & NRAS/KRAS Molecular Diagnostics / PCR
JAK2 V617F JAK2 V617F Molecular Diagnostics / PCR
KRAS KRAS Molecular Diagnostics / PCR
MGMT methylation status determined by bisulphite conversion measurement MGMT methylation status determined by bisulphite conversion measurement Molecular Diagnostics / PCR
Microsatellite instability by Microsatellite instability by Molecular Diagnostics / PCR
PCR and analysis of microsatellite markers PCR and analysis of microsatellite markers Molecular Diagnostics / PCR
TPMT TPMT Molecular Diagnostics / PCR
Tri/tetra nucleotide repeat fragment detection and interpretation (including PCR and TP-PCR) Tri/tetra nucleotide repeat fragment detection and interpretation (including PCR and TP-PCR) Molecular Diagnostics / PCR
X-inactivation X-inactivation Molecular Diagnostics / PCR
Analytic capacity as per SOP Analytic capacity as per SOP Other
Antibodies listed below:  -Dystroglycan  -Sarcoglycan measurement Antibodies listed below:  -Dystroglycan  -Sarcoglycan measurement Other
Break-apart probes Break-apart probes Other
By detection of microscopic chromosomal imbalance (gains and losses) expressed as changes to copy number measurement By detection of microscopic chromosomal imbalance (gains and losses) expressed as changes to copy number measurement Other
Copy Number/Amplification Copy Number/Amplification Other
Deletion Deletion Other
Detection of chromosomal aberrations in the diagnosis of Haematological malignancy, bone marrow failure syndromes Detection of chromosomal aberrations in the diagnosis of Haematological malignancy, bone marrow failure syndromes Other
Detection of chromosomal rearrangements or aberrations arising from (e.g) Detection of chromosomal rearrangements or aberrations arising from (e.g) Other
Determination of copy number – deletions and duplications- analytic capacity as per Determination of copy number – deletions and duplications- analytic capacity as per Other
Fusion products Fusion products Other
GENE51 GENE51 Other
Genetic examination for the purposes of clinical diagnosis Genetic examination for the purposes of clinical diagnosis Other
Haemato-Oncology and Solid Haemato-Oncology and Solid Other
Hypercholesterolemia and inherited cancers -analytic capacity as per GENE174 Hypercholesterolemia and inherited cancers -analytic capacity as per GENE174 Other
Identity / zygosity testing Identity / zygosity testing Other
Immunoblotting analysis and interpretation of data to progress a diagnosis Immunoblotting analysis and interpretation of data to progress a diagnosis Other
Insertion Insertion Other
Loss of pregnancy Loss of pregnancy Other
Monitoring stem-cell transplants Monitoring stem-cell transplants Other
Muscle Immunoanalysis Muscle Immunoanalysis Other
NUDT15 NUDT15 Other
Neoplastic Genetics including Neoplastic Genetics including Other
Non-haematological malignancies Non-haematological malignancies Other
Postnatal Disorders Postnatal Disorders Other
Prenatal Diagnosis Prenatal Diagnosis Other
Preparative pre-examination steps listed first measurement Preparative pre-examination steps listed first measurement Other
Validation of splicing variants and fusion events measurement Validation of splicing variants and fusion events measurement Other

Send an Enquiry

Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.

Please select a test method from the list
Report incorrect or outdated information
0 labs selected
Compare